OraPharma, Inc.

Valeant ’s OTC business is strongest where the firm can leverage its relationships with doctors into recommendations, executives say. “I think one thing we've learned is that the OTC products that we

Valeant ’s OTC business is strongest where the firm can leverage its relationships with doctors into recommendations, executives say. “I think one thing we've learned is that the OTC products that we

Valeant Pharmaceuticals International Inc. CEO Mike Pearson described his company’s reorganization plans, including the elimination of up to 2,730 jobs as it absorbs the staff of newly acquired Ba

Valeant Pharmaceuticals International Inc. aims to acquire and grow assets with lasting value – including OTCs and generics – as the Canadian firm continues its aggressive, strategic expansion into